Disclosures for "Tracking Motor Impairment in People with Neurosarcoidosis")
-
Dr. Moss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. An immediate family member of Dr. Moss has stock in Pfizer. The institution of Dr. Moss has received research support from Novartis. The institution of Dr. Moss has received research support from Genentech.
-
Nicholas Thompson has nothing to disclose.
-
Daniel Culver has nothing to disclose.